Profile - To The Moon

Samoo

Posts · 4Posts · 4
Following · 0Following · 0
Followers · 0Followers · 0

- SamooSamoo
  ·2021-05-08
  Almost bought Nio
  Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1
  Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc and Nio Inc in the first quarter and bought shares in vaccine maker Moderna Inc, regulatory filings reveal.What Happened:Baillie Gifford, a 110-year-old asset management firm and an early investor in Tesla, sold 11.1 million shares, or 1.15% of the Elon Musk-led company’s total shares outstanding, reducing the fund’s holding by 40% in the EV maker from the previous quarter.The Scottish firm has been
  Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1
  207 Comment
  Like
  Share
  Report
- SamooSamoo
  ·2021-05-06
  My friends just flew delta back to the states
  Delta Expands Premium Economy Seating
  After pausing its retrofit program for about six months after the COVID-19 pandemic hit, Delta now plans to install its premium select product on all of its wide-body jets by next summer.
  Delta Expands Premium Economy Seating
  65 Comment
  3
  Share
  Report
- SamooSamoo
  ·2021-05-05
  Wow
  This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?
  Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against t
  This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?
  103 Comment
  Like
  Share
  Report
- SamooSamoo
  ·2021-05-05
  Wow
  Sorry, this post has been deleted
  129 Comment
  Like
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3582810754555523","uuid":"3582810754555523","gmtCreate":1619718483614,"gmtModify":1620266473883,"name":"Samoo","pinyin":"samoo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/34d5153ffbcb09e4a9b1f68433e0f5ef","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":49,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":104488498,"gmtCreate":1620403439314,"gmtModify":1704343301736,"author":{"id":"3582810754555523","authorId":"3582810754555523","name":"Samoo","avatar":"https://static.tigerbbs.com/34d5153ffbcb09e4a9b1f68433e0f5ef","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582810754555523","authorIdStr":"3582810754555523"},"themes":[],"htmlText":"Almost bought Nio","listText":"Almost bought Nio","text":"Almost bought Nio","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/104488498","repostId":"1171540841","repostType":4,"repost":{"id":"1171540841","kind":"news","pubTimestamp":1620377234,"share":"https://ttm.financial/m/news/1171540841?lang=&edition=fundamental","pubTime":"2021-05-07 16:47","market":"us","language":"en","title":"Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=1171540841","media":"benzinga","summary":"Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc and Nio Inc in the first quarter and bought shares in vaccine maker Moderna Inc, regulatory filings reveal.What Happened:Baillie Gifford, a 110-year-old asset management firm and an early investor in Tesla, sold 11.1 million shares, or 1.15% of the Elon Musk-led company’s total shares outstanding, reducing the fund’s holding by 40% in the EV maker from the previous quarter.The Scottish firm has been","content":"<p>Investment management firm Baillie Gifford shed significant stake in electric carmakers&nbsp;<b>Tesla Inc</b>&nbsp;and&nbsp;<b>Nio Inc</b>&nbsp;in the first quarter and bought shares in vaccine maker&nbsp;<b>Moderna Inc</b>, regulatory filings reveal.</p><p><b>What Happened:</b>Baillie Gifford, a 110-year-old asset management firm and an early investor in Tesla, sold 11.1 million shares, or 1.15% of the Elon Musk-led company’s total shares outstanding, reducing the fund’s holding by 40% in the EV maker from the previous quarter.</p><p>The Scottish firm has been lowering its stake in the company for a while and now owns about 1.7% of Tesla's outstanding shares at 16.22 million; in the previous quarter, the firm had&nbsp;sold 7.4 million shares.</p><p>The investment firm first bought 2.3 million&nbsp;Tesla shares in early 2013 when Tesla shares were trading under $8. Tesla shares closed 1.10% lower at $663.54 on Thursday and have fallen 6% so far this year.</p><p>In Nio, the investment firm sold about 15.9 million shares, reducing its holding by 14% but still holds a 7.12% stake in the Chinese electric vehicle company that has justannouncedambitious plans to enter the Norway electric vehicle market, its first overseas foray.</p><p>Nio shares closed 2.73% lower at $36.68 on Thursday.</p><p>The investment firm added position in vaccine maker Moderna — buying about 21 million shares, raising its stake to 11.3% in the Massachusetts-based company.</p><p>Moderna shares closed 1.44% lower at $160.50 on Thursday after the company reported its first quarterly profit helped by covid vaccine sales.</p><p>Some other stocks sold by the firm in Q1 included&nbsp;<b>Amazon.com Inc</b>,&nbsp;<b>Alphabet Inc</b>, and&nbsp;<b>Facebook Inc</b>.</p><p>Baillie Gifford’s Other Q1 buys included&nbsp;<b>Illumina Inc</b>(NASDAQ:ILMN),&nbsp;<b>Shopify Inc</b>(NYSE:SHOP), and&nbsp;<b>Spotify Technology</b>(NYSE:SPOT),&nbsp;<b>Clover Health Investments Corp</b>(NASDAQ:CLOV),&nbsp;<b>Snap Inc.</b>(NYSE:SNAP), and&nbsp;<b>Li Auto Inc.</b>(NYSE:LI).</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-07 16:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/long-ideas/21/05/21006676/tesla-nio-significantly-cut-from-baillie-gifford-portfolio-heres-what-the-firm-bought-in><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc and Nio Inc in the first quarter and bought shares in vaccine maker Moderna Inc, regulatory filings ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/05/21006676/tesla-nio-significantly-cut-from-baillie-gifford-portfolio-heres-what-the-firm-bought-in\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","MRNA":"Moderna, Inc.","TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/21/05/21006676/tesla-nio-significantly-cut-from-baillie-gifford-portfolio-heres-what-the-firm-bought-in","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171540841","content_text":"Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc and Nio Inc in the first quarter and bought shares in vaccine maker Moderna Inc, regulatory filings reveal.What Happened:Baillie Gifford, a 110-year-old asset management firm and an early investor in Tesla, sold 11.1 million shares, or 1.15% of the Elon Musk-led company’s total shares outstanding, reducing the fund’s holding by 40% in the EV maker from the previous quarter.The Scottish firm has been lowering its stake in the company for a while and now owns about 1.7% of Tesla's outstanding shares at 16.22 million; in the previous quarter, the firm had sold 7.4 million shares.The investment firm first bought 2.3 million Tesla shares in early 2013 when Tesla shares were trading under $8. Tesla shares closed 1.10% lower at $663.54 on Thursday and have fallen 6% so far this year.In Nio, the investment firm sold about 15.9 million shares, reducing its holding by 14% but still holds a 7.12% stake in the Chinese electric vehicle company that has justannouncedambitious plans to enter the Norway electric vehicle market, its first overseas foray.Nio shares closed 2.73% lower at $36.68 on Thursday.The investment firm added position in vaccine maker Moderna — buying about 21 million shares, raising its stake to 11.3% in the Massachusetts-based company.Moderna shares closed 1.44% lower at $160.50 on Thursday after the company reported its first quarterly profit helped by covid vaccine sales.Some other stocks sold by the firm in Q1 included Amazon.com Inc, Alphabet Inc, and Facebook Inc.Baillie Gifford’s Other Q1 buys included Illumina Inc(NASDAQ:ILMN), Shopify Inc(NYSE:SHOP), and Spotify Technology(NYSE:SPOT), Clover Health Investments Corp(NASDAQ:CLOV), Snap Inc.(NYSE:SNAP), and Li Auto Inc.(NYSE:LI).","news_type":1},"isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102456771,"gmtCreate":1620235058293,"gmtModify":1704340616016,"author":{"id":"3582810754555523","authorId":"3582810754555523","name":"Samoo","avatar":"https://static.tigerbbs.com/34d5153ffbcb09e4a9b1f68433e0f5ef","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582810754555523","authorIdStr":"3582810754555523"},"themes":[],"htmlText":"My friends just flew delta back to the states&nbsp;","listText":"My friends just flew delta back to the states&nbsp;","text":"My friends just flew delta back to the states","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102456771","repostId":"2133452553","repostType":4,"repost":{"id":"2133452553","kind":"highlight","pubTimestamp":1620225300,"share":"https://ttm.financial/m/news/2133452553?lang=&edition=fundamental","pubTime":"2021-05-05 22:35","market":"us","language":"en","title":"Delta Expands Premium Economy Seating","url":"https://stock-news.laohu8.com/highlight/detail?id=2133452553","media":"Motley Fool","summary":"After pausing its retrofit program for about six months after the COVID-19 pandemic hit, Delta now plans to install its premium select product on all of its wide-body jets by next summer.","content":"<p>Prior to the COVID-19 pandemic, <b>Delta Air Lines</b> (NYSE:DAL) planned to install premium economy seats on its entire international wide-body fleet by the end of this year. However, the pandemic forced it to halt all non-essential capital spending for a while.</p><p>Delta has since resumed its retrofit program to install what it calls \"premium select\" sections on its remaining wide-body fleet types. This looks like a smart move for the full-service airline.</p><h2>Rollout in progress</h2><p>In 2017, Delta Air Lines began installing premium select cabins on some of the wide-body jets it used for long-haul flights. Initially, it planned to offer premium economy seating on a relatively small proportion of its wide-body fleet: specifically, the <b>Airbus </b>A350 and <b>Boeing </b>777 jets that operated its longest international routes.</p><p>Management quickly changed its tune due to the massive success of its initial rollout of premium select. With fares for the new product averaging more than double the average coach fare, Delta promised in mid-2018 to bring premium select to all of its wide-bodies by 2021.</p><p>The A330-900neos that entered Delta's fleet beginning in 2019 have all come with premium select cabins included. Delta also began retrofitting its 767-400ER fleet in 2019. While Delta paused that work for part of 2020, it has now finished the retrofits on all but two of its 767-400ERs.</p><p>On the flip side, Delta retired all of its 777s last year to simplify its fleet. As a result, barely more than a third of the airline's wide-body fleet features premium select seating today, leaving the airline well short of its goal of a fleetwide rollout by year-end.</p><h2>Getting back on track</h2><p>On Tuesday, Delta Air Lines announced that it is beginning to install premium select cabins on its 767-300ERs and A330s: the last two wide-body fleet types without this key product. The first 767-300ER with premium select seating will be ready this month, while reconfigured A330s will join the fleet beginning in July.</p><p>Delta currently has 36 767-300ERs and 42 current-generation A330s in its fleet. Since long-haul demand remains extremely weak for now due to international travel restrictions, the airline can afford to have a significant number of 767-300ERs and A330s out of service simultaneously for modifications. That will allow it to complete all of the retrofits by the summer of 2022.</p><h2>The right product for the post-pandemic period</h2><p>A number of pundits criticized Delta's recent announcement, noting that the carrier isn't upgrading the somewhat dated Delta One first-class cabins on its 767-300ERs and A330s.</p><p>This decision isn't surprising, though. Airlines rely on high-spending business travelers to fill the pricey lie-flat seats they deploy in first class and business class on long-haul routes. However, it could take another two or three years for business travel demand to recover -- and it may never reach pre-pandemic levels again. Moreover, Delta plans to retire all of its 767-300ERs by the end of 2025.</p><p>By contrast, international premium economy is an affordable luxury. U.S. consumers are sitting on an estimated $2.6 trillion of excess savings, thanks to lower spending on travel, restaurants, and entertainment during the pandemic, as well as generous government stimulus payments. That could unleash huge demand for Delta's premium select seats as international leisure travel demand recovers over the next year or two.</p><p>Delta's willingness to invest in premium select retrofits for its 767-300ERs despite their planned retirement in 2025 suggests that it expects a very quick payback period for this investment. That's great news for investors. There will be plenty of time to move forward with upgrading the Delta One cabin on the A330 fleet in a year or two, depending on the strength of the business travel demand recovery.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Delta Expands Premium Economy Seating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDelta Expands Premium Economy Seating\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 22:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/05/delta-expands-premium-economy-seating/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Prior to the COVID-19 pandemic, Delta Air Lines (NYSE:DAL) planned to install premium economy seats on its entire international wide-body fleet by the end of this year. However, the pandemic forced it...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/05/delta-expands-premium-economy-seating/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DAL":"达美航空"},"source_url":"https://www.fool.com/investing/2021/05/05/delta-expands-premium-economy-seating/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133452553","content_text":"Prior to the COVID-19 pandemic, Delta Air Lines (NYSE:DAL) planned to install premium economy seats on its entire international wide-body fleet by the end of this year. However, the pandemic forced it to halt all non-essential capital spending for a while.Delta has since resumed its retrofit program to install what it calls \"premium select\" sections on its remaining wide-body fleet types. This looks like a smart move for the full-service airline.Rollout in progressIn 2017, Delta Air Lines began installing premium select cabins on some of the wide-body jets it used for long-haul flights. Initially, it planned to offer premium economy seating on a relatively small proportion of its wide-body fleet: specifically, the Airbus A350 and Boeing 777 jets that operated its longest international routes.Management quickly changed its tune due to the massive success of its initial rollout of premium select. With fares for the new product averaging more than double the average coach fare, Delta promised in mid-2018 to bring premium select to all of its wide-bodies by 2021.The A330-900neos that entered Delta's fleet beginning in 2019 have all come with premium select cabins included. Delta also began retrofitting its 767-400ER fleet in 2019. While Delta paused that work for part of 2020, it has now finished the retrofits on all but two of its 767-400ERs.On the flip side, Delta retired all of its 777s last year to simplify its fleet. As a result, barely more than a third of the airline's wide-body fleet features premium select seating today, leaving the airline well short of its goal of a fleetwide rollout by year-end.Getting back on trackOn Tuesday, Delta Air Lines announced that it is beginning to install premium select cabins on its 767-300ERs and A330s: the last two wide-body fleet types without this key product. The first 767-300ER with premium select seating will be ready this month, while reconfigured A330s will join the fleet beginning in July.Delta currently has 36 767-300ERs and 42 current-generation A330s in its fleet. Since long-haul demand remains extremely weak for now due to international travel restrictions, the airline can afford to have a significant number of 767-300ERs and A330s out of service simultaneously for modifications. That will allow it to complete all of the retrofits by the summer of 2022.The right product for the post-pandemic periodA number of pundits criticized Delta's recent announcement, noting that the carrier isn't upgrading the somewhat dated Delta One first-class cabins on its 767-300ERs and A330s.This decision isn't surprising, though. Airlines rely on high-spending business travelers to fill the pricey lie-flat seats they deploy in first class and business class on long-haul routes. However, it could take another two or three years for business travel demand to recover -- and it may never reach pre-pandemic levels again. Moreover, Delta plans to retire all of its 767-300ERs by the end of 2025.By contrast, international premium economy is an affordable luxury. U.S. consumers are sitting on an estimated $2.6 trillion of excess savings, thanks to lower spending on travel, restaurants, and entertainment during the pandemic, as well as generous government stimulus payments. That could unleash huge demand for Delta's premium select seats as international leisure travel demand recovers over the next year or two.Delta's willingness to invest in premium select retrofits for its 767-300ERs despite their planned retirement in 2025 suggests that it expects a very quick payback period for this investment. That's great news for investors. There will be plenty of time to move forward with upgrading the Delta One cabin on the A330 fleet in a year or two, depending on the strength of the business travel demand recovery.","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102410224,"gmtCreate":1620229727568,"gmtModify":1704340558616,"author":{"id":"3582810754555523","authorId":"3582810754555523","name":"Samoo","avatar":"https://static.tigerbbs.com/34d5153ffbcb09e4a9b1f68433e0f5ef","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582810754555523","authorIdStr":"3582810754555523"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102410224","repostId":"1131387668","repostType":4,"repost":{"id":"1131387668","kind":"news","pubTimestamp":1620228331,"share":"https://ttm.financial/m/news/1131387668?lang=&edition=fundamental","pubTime":"2021-05-05 23:25","market":"us","language":"en","title":"This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?","url":"https://stock-news.laohu8.com/highlight/detail?id=1131387668","media":"benzinga","summary":"Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against t","content":"<p>Shares of<b>BioNTech SE</b>, which&nbsp;partnered with<b>Pfizer Inc.</b>&nbsp;in successfully developing a vaccine against the coronavirus, have been gaining ground.</p>\n<p><b>BioNTech's Price Action:</b>BioNTech and its partner Pfizerreceived in mid-Decemberauthorization for emergency use of the&nbsp;BNT162b2 mRNA vaccine&nbsp;against the novel coronavirus that causes COVID-19.</p>\n<p>BioNTech's shares, which rallied to a high of $131 ahead of the FDA decision, gave back part of the gains in a ‘buy-the-rumor, sell-the-news' move. The stock ended 2020 at $81.52, about 38% off the intraday high for the year.</p>\n<p>The German vaccine maker's stock picked up momentum early in 2021, breaching&nbsp;the $100 psychological resistance level on Jan. 8 and trading&nbsp;in a $100-$120 range until early March.</p>\n<p>The marketwide selloff in March did not spare BioNTech, with the stock dropping below $100 for a few sessions before climbing back again. The stock was locked in a lackluster phase until the end of March.</p>\n<p>Come April, the trend began to change. In the very first session of April, the stock rose over 4% and moved steadily higher through the month. In April alone, the stock added 72.4%.</p>\n<p>To put things in perspective, if an investor had invested $1,000 in BioNTech shares at the end of March, their investment would now be worth $1,909.46 (using the intraday high of $207.55 hit on Monday). This would mean nearly doubling the investment in a span of a month.</p>\n<p><b>What's Behind The BioNTech Rally:</b>The stock has been supported by the intermittent news flow regarding the company's vaccine.</p>\n<p>In late March, the companies reported positive top-line results from a study evaluating the vaccine in adolescents.</p>\n<p>On April 1, BioNTech and Pfizer reported data on BNT162b2 following six months of follow-up that confirmed its efficacy and safety.</p>\n<p>The companies announced April 9 a request to the FDA to authorize&nbsp;expanded use of the vaccine in adolescents ages&nbsp;12-15.</p>\n<p>The FDA'sdecisionto temporarily pause the use of<b>Johnson &amp; Johnson's</b>JNJ 0.2%vaccine also proved positive for BioNTech, which added about 7% on April 13&nbsp;when the pause was announced.</p>\n<p>In mid-April, the companies announced an agreement with the European Union to supply 100 million doses of BNT162b2, which is named Comirnaty in Europe, in 2021. With that, the total number of doses delivered to the EU is 600 million.</p>\n<p>Last week, a request was submitted to the EU to expand conditional marketing authorization to adolescents in the EU.</p>\n<p><b>What Lies Ahead For BioNTech Stock?</b>BNT162b2 is expected to continue to boost BioNTech's top-line. Having delivered 200 million doses by the end of March, the company has signed orders for supplying 1.4 billion doses in 2021.</p>\n<p>Pfizer and BioNTech plan to boost the manufacturing capacity for&nbsp;the vaccine to 2.5 billion doses by the end of 2021.</p>\n<p>\"BioNTech and Pfizer will be the standout leader in COVID-19 vaccination globally, with demand increasing for the 2.5Bn doses they are targeting to manufacture in 2021,\" SVB Leerink analyst Daina Graybosch said in a note.</p>\n<p>With the second wave of the COVID-19 pandemic now sweeping across several nations, the&nbsp;companies have a lucrative opportunity.&nbsp;The companies have also proved the efficacy of the&nbsp;vaccine against variants.</p>\n<p>Once the pandemic phase passes, the vaccine has scope for use in endemic setting.</p>\n<p>More importantly, BioNTech is not a one-trick pony. The company has a broad oncology pipeline&nbsp;consisting of 13 product candidates.</p>\n<p>Weighing in all the opportunities, further upside in the stock cannot be ruled out.</p>\n<p><b>BNTX Price Action:</b>At last check, BioNTech shares were rising 8.2% to $191.38.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground.\nBioNTech's Price Action:BioNTech and its partner ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131387668","content_text":"Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground.\nBioNTech's Price Action:BioNTech and its partner Pfizerreceived in mid-Decemberauthorization for emergency use of the BNT162b2 mRNA vaccine against the novel coronavirus that causes COVID-19.\nBioNTech's shares, which rallied to a high of $131 ahead of the FDA decision, gave back part of the gains in a ‘buy-the-rumor, sell-the-news' move. The stock ended 2020 at $81.52, about 38% off the intraday high for the year.\nThe German vaccine maker's stock picked up momentum early in 2021, breaching the $100 psychological resistance level on Jan. 8 and trading in a $100-$120 range until early March.\nThe marketwide selloff in March did not spare BioNTech, with the stock dropping below $100 for a few sessions before climbing back again. The stock was locked in a lackluster phase until the end of March.\nCome April, the trend began to change. In the very first session of April, the stock rose over 4% and moved steadily higher through the month. In April alone, the stock added 72.4%.\nTo put things in perspective, if an investor had invested $1,000 in BioNTech shares at the end of March, their investment would now be worth $1,909.46 (using the intraday high of $207.55 hit on Monday). This would mean nearly doubling the investment in a span of a month.\nWhat's Behind The BioNTech Rally:The stock has been supported by the intermittent news flow regarding the company's vaccine.\nIn late March, the companies reported positive top-line results from a study evaluating the vaccine in adolescents.\nOn April 1, BioNTech and Pfizer reported data on BNT162b2 following six months of follow-up that confirmed its efficacy and safety.\nThe companies announced April 9 a request to the FDA to authorize expanded use of the vaccine in adolescents ages 12-15.\nThe FDA'sdecisionto temporarily pause the use ofJohnson & Johnson'sJNJ 0.2%vaccine also proved positive for BioNTech, which added about 7% on April 13 when the pause was announced.\nIn mid-April, the companies announced an agreement with the European Union to supply 100 million doses of BNT162b2, which is named Comirnaty in Europe, in 2021. With that, the total number of doses delivered to the EU is 600 million.\nLast week, a request was submitted to the EU to expand conditional marketing authorization to adolescents in the EU.\nWhat Lies Ahead For BioNTech Stock?BNT162b2 is expected to continue to boost BioNTech's top-line. Having delivered 200 million doses by the end of March, the company has signed orders for supplying 1.4 billion doses in 2021.\nPfizer and BioNTech plan to boost the manufacturing capacity for the vaccine to 2.5 billion doses by the end of 2021.\n\"BioNTech and Pfizer will be the standout leader in COVID-19 vaccination globally, with demand increasing for the 2.5Bn doses they are targeting to manufacture in 2021,\" SVB Leerink analyst Daina Graybosch said in a note.\nWith the second wave of the COVID-19 pandemic now sweeping across several nations, the companies have a lucrative opportunity. The companies have also proved the efficacy of the vaccine against variants.\nOnce the pandemic phase passes, the vaccine has scope for use in endemic setting.\nMore importantly, BioNTech is not a one-trick pony. The company has a broad oncology pipeline consisting of 13 product candidates.\nWeighing in all the opportunities, further upside in the stock cannot be ruled out.\nBNTX Price Action:At last check, BioNTech shares were rising 8.2% to $191.38.","news_type":1},"isVote":1,"tweetType":1,"viewCount":103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102437162,"gmtCreate":1620229638956,"gmtModify":1704340556842,"author":{"id":"3582810754555523","authorId":"3582810754555523","name":"Samoo","avatar":"https://static.tigerbbs.com/34d5153ffbcb09e4a9b1f68433e0f5ef","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582810754555523","authorIdStr":"3582810754555523"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102437162","repostId":"1131387668","repostType":4,"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}